A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2, 6-MONTH STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND EXPLORATORY EFFICACY OF CT1812 IN SUBJECTS WITH MILD TO MODERATE DEMENTIA WITH LEWY BODIES
Details
Age
Adult
Type of Study
Treatment
Locations
Brain Imaging Center - BIC
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
Samantha Holden, MD
Study ID
Protocol Number: 22-0669
More information available at ClinicalTrials.gov: NCT05225415
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers